Wednesday, November 4, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Data updated Nov 4, 2026·New filings added every weekday·Weekly prices as of Oct 2·What changed·
Insider tradingForm 4

Bambusa Therapeutics, Inc. (BBTX) Insider Trading

4 open-market trades reported since Nov 2, 2026: 4 purchases worth $58.6M and 0 sales worth $0.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Ra Capital Management, L.P.Director2$46.6M0$0Nov 3, 2026
Helmut Wolfgang JeggleDirector1$6.00M0$0Nov 2, 2026
Salvia Investment GmbH10% owner1$6.00M0$0Nov 2, 2026

All trades

BBTX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHolding3 mo. afterFiling
Nov 3Nov 2Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY2,500,00016.00$40.0M62NewForm 4 ↗
Nov 3Oct 30Ra Capital Management, L.P.DirectorDirector (ind.)▲ BUY453,82014.63$6.64M70NewForm 4 ↗
Nov 2Nov 2Helmut Wolfgang JeggleDirectorDirector (ind.)▲ BUY375,00016.00$6.00M52+4.2%Form 4 ↗
Nov 2Nov 2Salvia Investment GmbH10% owner10% owner▲ BUY375,00016.00$6.00M48+4.2%Form 4 ↗
Source: SEC Form 4 filings, retrieved Nov 4, 2026. How we read filings

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.